Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis

A Stefferl, A Schubart, M Storch, A Amini… - The journal of …, 2000 - journals.aai.org
A Stefferl, A Schubart, M Storch, A Amini, I Mather, H Lassmann, C Linington
The journal of Immunology, 2000journals.aai.org
Experimental autoimmune encephalomyelitis (EAE) induced by sensitization with myelin
oligodendrocyte glycoprotein (MOG) is a T cell-dependent autoimmune disease that
reproduces the inflammatory demyelinating pathology of multiple sclerosis. We report that
an encephalitogenic T cell response to MOG can be either induced or alternatively
suppressed as a consequence of immunological cross-reactivity, or “molecular mimicry” with
the extracellular IgV-like domain of the milk protein butyrophilin (BTN). In the Dark Agouti rat …
Abstract
Experimental autoimmune encephalomyelitis (EAE) induced by sensitization with myelin oligodendrocyte glycoprotein (MOG) is a T cell-dependent autoimmune disease that reproduces the inflammatory demyelinating pathology of multiple sclerosis. We report that an encephalitogenic T cell response to MOG can be either induced or alternatively suppressed as a consequence of immunological cross-reactivity, or “molecular mimicry” with the extracellular IgV-like domain of the milk protein butyrophilin (BTN). In the Dark Agouti rat, active immunization with native BTN triggers an inflammatory response in the CNS characterized by the formation of scattered meningeal and perivascular infiltrates of T cells and macrophages. We demonstrate that this pathology is mediated by a MHC class II-restricted T cell response that cross-reacts with the MOG peptide sequence 76–87, I G EG K VA L RIQ N (identities underlined). Conversely, molecular mimicry with BTN can be exploited to suppress disease activity in MOG-induced EAE. We demonstrate that not only is EAE mediated by the adoptive transfer of MOG 74–90 T cell lines markedly ameliorated by iv treatment with the homologous BTN peptide, BTN 74–90, but that this protective effect is also seen in actively induced disease following transmucosal (intranasal) administration of the peptide. These results identify a mechanism by which the consumption of milk products may modulate the pathogenic autoimmune response to MOG.
journals.aai.org